FDA Clears First Nasal Testosterone Therapy
The product is self-administered via a nasal applicator.
The product is self-administered via a nasal applicator.
Researchers find link among patients with subclinical hyperthyroidism and euthyroid sick syndrome.
Study of 1,146 radical prostatectomy patients reveals a 36% decreased risk of PSA relapse in those who used statins after surgery.
This parameter can identify prostate cancer patients for whom adjuvant radiation therapy after radical prostatectomy may be of no benefit.
Their risk of death is 40% lower than that of patients who are not obese, study shows.
Even multiple treatments have a negligible effect, Canadian researchers concluded.
In a study, the re-intervention rate was 11% for patients treated with shock wave lithotripsy versus 0.2% of those who had ureteroscopy.
The 5-year disease-free and cancer-specific survival rates were 94.7% and 100%, respectively.